Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose oral minoxidil increases hair thickness and length in children with a hair disorder called Loose Anagen Hair Syndrome.

The HairLux device safely and effectively promotes hair growth in people with hair loss.

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.

The document concluded that cyproterone acetate and minoxidil are effective for female hair loss, and a supportive doctor-patient relationship is important.

Chemotherapy patients don't all lose their hair due to factors like hair growth rates, age, genetics, and the type of drugs used.

Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.

The conclusion is that detailed clinical descriptions help pathologists diagnose hair loss conditions more accurately.

Telogen effluvium is a common hair loss condition that can be managed with proper treatment and addressing underlying issues.

COVID-19 patients in Thailand typically started losing hair about 30 days after infection, with women experiencing more severe hair loss.

Effective treatment for midlife women's hair loss is limited, with 5% minoxidil foam being the only proven option for the most common type.

Male hair loss is mainly due to thinner hair, not less hair.

Hair loss can happen after severe H1N1 flu but usually grows back in 4 months.

The document provided instructions for completing a CME exam on diagnosing and managing hair loss.

Colchicine causes hair loss by damaging hair follicles.

New methods can diagnose hair loss by examining the scalp and can treat it with a mix of oral and topical medications, along with cosmetic procedures like hair transplants.

People with Telogen Effluvium often lack vitamin D, ferritin, and zinc.

Chemotherapy improved a girl's painful foot condition linked to pachyonychia congenita.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Systemic diseases can cause hair loss, which is often reversible with treatment.

People with HIV and low T cell counts have more hair and scalp problems.

Most hair loss can be diagnosed with patient history and physical exam, and a few common types make up most cases.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

The review highlights the importance of stem cells in hair health and suggests new treatment strategies for hair loss conditions.

Almost half of COVID-19 patients in Makkah, Saudi Arabia experienced increased hair loss, especially women and those with chronic diseases.

Scalp biopsies are important for diagnosing hair loss conditions.

The conclusion is that three signs can help diagnose hair loss after it happens, potentially avoiding more invasive tests.

The document concludes that understanding hair biology and recognizing hair conditions are crucial for managing and treating hair loss in children.